Cardiovascular (CV) and pulmonary adverse events (AES) in patients (PTS) treated with BCR-ABL tyrosine kinase inhibitors (TKIS): Updated analysis from the FDA Adverse Event Reporting System (FAERS) Meeting Abstract
| Authors: | Cortes, J.; Mauro, M.; Steegmann, J. L.; Saglio, G.; Soitkar, A.; Wallis, N. |
| Abstract Title: | Cardiovascular (CV) and pulmonary adverse events (AES) in patients (PTS) treated with BCR-ABL tyrosine kinase inhibitors (TKIS): Updated analysis from the FDA Adverse Event Reporting System (FAERS) |
| Meeting Title: | 20th Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 100 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Jun 11-14 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2015-06-01 |
| Start Page: | 231 |
| Language: | English |
| ACCESSION: | WOS:000361204902106 |
| PROVIDER: | wos |
| PMCID: | PMC4480587 |
| Notes: | Meeting Abstract: P601 -- Source: Wos |
MSK Authors
-
267Mauro
Related MSK Work